Diprotin A (Synonyms:Ile-Pro-Ile;抑二肽素A)
目录号 : KCM15691 CAS No. : 90614-48-5 纯度 : ≥98%
Diprotin A is a tripeptide inhibitor of dipeptidyl peptidase 4 (DPP-4; IC = 1.1 μg/ml). It inhibits degradation of glucagon-like peptide 1 (GLP-1; ) in culture with insulin-secreting BRIN-BD11 rat pancreatic β-cells when used at a concentration of 25 μM. Diprotin A (5 mg/ml) pre-incubation enhances chemotaxis of murine embryonic stem cells towards stromal cell-derived factor-1 (SDF-1/CXCL12) in vitro. Pre-incubation of CD34 human umbilical cord blood cells with diprotin A (5 mM) prior to injection increases engraftment in NOD/SCID recipient mice.
规格 价格 是否有货 数量
10mg
In-stock
25mg
In-stock
50mg
In-stock
100mg
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

Diprotin A is an inhibitor of dipeptidyl peptidase IV (DPP-IV).

IC50&Target

DPP-4

体外研究

Diprotin A (100 μ M; 30 minutes after treatment with CXCR4 blocker or Src inhibitor) induces phosphorylation of Src [Tyr 416] and VE cadherin [Tyr731] in hEC under normoxic and H/R conditions in human endothelial cells, and disrupts CXCR4 (SDF-1 α receptor) blockade or Src inhibitor to weaken endothelial cell junctions.

 

Western Blot Analysis

Cell Line: Human endothelial cells
Concentration: 100 μM
Incubation Time: 30 minutes after CXCR4-blocker or Src-inhibitor treatment
Result: Induced the phosphorylation of Src [Tyr 416] and VE-cadherin [Tyr731] in hECs.
体内研究

Diprotin A (100 μM; 30 minutes after treatment with CXCR4 blocker or Src inhibitor) induces phosphorylation of Src [Tyr 416] and VE cadherin [Tyr731] in hEC under normoxic and H/R conditions in human endothelial cells, and disrupts CXCR4 (SDF-1 α receptor) blockade or Src inhibitor to weaken endothelial cell junctions.

 

Animal Model: Streptozotocin-induced diabetic retinopathy model in wild-type C57/BL6 mice
Dosage: 70 μg/kg
Administration: Intraperitoneal injection; twice daily; 7 days
Result:
Induced vascular leakage by augmenting the SDF-1α/CXCR4/Src/VE-cadherin signaling pathway.
 
分子式
C17H31N3O4
分子量
341.45
CAS号
90614-48-5
中文名称
抑二肽素A
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式

-20°C, sealed storage, away from moisture and light, under nitrogen

* In solvent : -80°C, 6 months; -20°C, 1 month sealed storage, away from moisture and light, under nitrogen)

溶解性数据
In Vitro: 

H2O : ≥ 100 mg/mL (292.87 mM)

DMSO : 100 mg/mL (292.87 mM; Need ultrasonic)

* "≥" means soluble, but saturation unknown.

配制储备液
                                           
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
                                                                                                                    
1 mM 2.9287 mL 14.6434 mL 29.2869 mL
5 mM 0.5857 mL 2.9287 mL 5.8574 mL
10 mM 0.2929 mL 1.4643 mL 2.9287 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积:

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。